Found: 19
Select item for more details and to access through your institution.
Innentitelbild: Pigmentierungschemie und radikalbasierter Kollagenabbau bei Alkaptonurie und Arthrose (Angew. Chem. 29/2020).
- Published in:
- Angewandte Chemie, 2020, v. 132, n. 29, p. 11770, doi. 10.1002/ange.202005824
- By:
- Publication type:
- Article
Pigmentierungschemie und radikalbasierter Kollagenabbau bei Alkaptonurie und Arthrose.
- Published in:
- Angewandte Chemie, 2020, v. 132, n. 29, p. 12035, doi. 10.1002/ange.202000618
- By:
- Publication type:
- Article
Post-Transcriptional Regulatory Crosstalk between MicroRNAs and Canonical TGF-β/BMP Signalling Cascades on Osteoblast Lineage: A Comprehensive Review.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 7, p. 6423, doi. 10.3390/ijms24076423
- By:
- Publication type:
- Article
The Regulatory Role of MicroRNAs in Breast Cancer.
- Published in:
- International Journal of Molecular Sciences, 2019, v. 20, n. 19, p. 4940, doi. 10.3390/ijms20194940
- By:
- Publication type:
- Article
Revisiting Quantification of Phenylalanine/Tyrosine Flux in the Ochronotic Pathway during Long-Term Nitisinone Treatment of Alkaptonuria.
- Published in:
- Metabolites (2218-1989), 2022, v. 12, n. 10, p. 920, doi. 10.3390/metabo12100920
- By:
- Publication type:
- Article
Comprehensive Biotransformation Analysis of Phenylalanine-Tyrosine Metabolism Reveals Alternative Routes of Metabolite Clearance in Nitisinone-Treated Alkaptonuria.
- Published in:
- Metabolites (2218-1989), 2022, v. 12, n. 10, p. 927, doi. 10.3390/metabo12100927
- By:
- Publication type:
- Article
Comparing the Phenylalanine/Tyrosine Pathway and Related Factors between Keratopathy and No-Keratopathy Groups as Well as between Genders in Alkaptonuria during Nitisinone Treatment.
- Published in:
- Metabolites (2218-1989), 2022, v. 12, n. 8, p. 772, doi. 10.3390/metabo12080772
- By:
- Publication type:
- Article
Impact of Nitisinone on the Cerebrospinal Fluid Metabolome of a Murine Model of Alkaptonuria.
- Published in:
- Metabolites (2218-1989), 2022, v. 12, n. 6, p. 477, doi. 10.3390/metabo12060477
- By:
- Publication type:
- Article
Increased prevalence of Parkinson's disease in alkaptonuria.
- Published in:
- Journal of Inherited Metabolic Disease Reports, 2023, v. 64, n. 4, p. 282, doi. 10.1002/jmd2.12367
- By:
- Publication type:
- Article
Comparing nitisinone 2 mg and 10 mg in the treatment of alkaptonuria—An approach using statistical modelling.
- Published in:
- Journal of Inherited Metabolic Disease Reports, 2022, v. 63, n. 1, p. 80, doi. 10.1002/jmd2.12261
- By:
- Publication type:
- Article
Evaluation of the serum metabolome of patients with alkaptonuria before and after two years of treatment with nitisinone using LC-QTOF-MS.
- Published in:
- Journal of Inherited Metabolic Disease Reports, 2019, v. 48, n. 1, p. 67, doi. 10.1002/jmd2.12042
- By:
- Publication type:
- Article
Early Onset Parkinson's Disease in a family of Moroccan origin caused by a p.A217D mutation in PINK1: a case report.
- Published in:
- 2017
- By:
- Publication type:
- journal article
A Comprehensive LC-QTOF-MS Metabolic Phenotyping Strategy: Application to Alkaptonuria.
- Published in:
- Clinical Chemistry, 2019, v. 65, n. 4, p. 530, doi. 10.1373/clinchem.2018.295345
- By:
- Publication type:
- Article
Inside Cover: Pigmentation Chemistry and Radical‐Based Collagen Degradation in Alkaptonuria and Osteoarthritic Cartilage (Angew. Chem. Int. Ed. 29/2020).
- Published in:
- Angewandte Chemie International Edition, 2020, v. 59, n. 29, p. 11674, doi. 10.1002/anie.202005824
- By:
- Publication type:
- Article
Pigmentation Chemistry and Radical‐Based Collagen Degradation in Alkaptonuria and Osteoarthritic Cartilage.
- Published in:
- Angewandte Chemie International Edition, 2020, v. 59, n. 29, p. 11937, doi. 10.1002/anie.202000618
- By:
- Publication type:
- Article
Nitisinone causes acquired tyrosinosis in alkaptonuria.
- Published in:
- Journal of Inherited Metabolic Disease, 2020, v. 43, n. 5, p. 1014, doi. 10.1002/jimd.12229
- By:
- Publication type:
- Article
Homogentisic acid is not only eliminated by glomerular filtration and tubular secretion but also produced in the kidney in alkaptonuria.
- Published in:
- Journal of Inherited Metabolic Disease, 2020, v. 43, n. 4, p. 737, doi. 10.1002/jimd.12181
- By:
- Publication type:
- Article
Ochronotic pigmentation is caused by homogentisic acid and is the key event in alkaptonuria leading to the destructive consequences of the disease—A review.
- Published in:
- Journal of Inherited Metabolic Disease, 2019, v. 42, n. 5, p. 776, doi. 10.1002/jimd.12152
- By:
- Publication type:
- Article
Conditional targeting in mice reveals that hepatic homogentisate 1,2-dioxygenase activity is essential in reducing circulating homogentisic acid and for effective therapy in the genetic disease alkaptonuria.
- Published in:
- Human Molecular Genetics, 2019, v. 28, n. 23, p. 3928, doi. 10.1093/hmg/ddz234
- By:
- Publication type:
- Article